Mc Clarren Financial Advisors, Inc. Agenus Inc Transaction History

Mc Clarren Financial Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$0.45 - $17.57 $0 - $35	-2 Closed	0 $0
Q1 2024 Jul 26, 2024	BUY	$0.53 - $0.93 $0 - $0	1 Added 100.0%	2 $1,000
Q1 2024 May 03, 2024	SELL	$0.53 - $0.93 $0 - $0	-1 Reduced 50.0%	1 $1,000
Q3 2022 Oct 31, 2022	BUY	$1.96 - $3.14 $3 - $6	2 New	2 $0
Q2 2022 Aug 11, 2022	SELL	$1.3 - $2.64 $2 - $5	-2 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$3.17 - $4.49 $6 - $8	2 New	2 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.